LABIQ Trademark Application - Intent to Use

The USPTO received an Intent to Use trademark application for LABIQ (TM99032176) under Class 044 (Medical Services). The application covers software for laboratory information management, telemedicine, healthcare operations, medical testing workflow automation, AI analytics, and related services. No compliance deadlines or regulatory requirements are imposed by this filing.

Disease Diagnosis System Using Multiple Color Models and Neural Network

The European Patent Office published patent application EP3819910A2 for Deep Bio Inc., covering a disease diagnosis system that uses multiple color models and neural network processing. The patent application was published on March 25, 2026, with inventors LEE Sang Hun and KIM Sun Woo. This patent grants exclusive rights to the disclosed medical diagnostic technology across all EPO-designated contracting states.

Tumor Visualization and Removal Devices Systems and Methods

The European Patent Office published patent application EP3745951A1 for University Health Network covering devices, systems, and methods for tumor visualization and removal. The patent includes claims related to medical imaging technology for identifying and removing tumors, filed by inventors Dacosta, Gibson, Ottolino-Perry, and colleagues.

Glytec Diabetes Medication Insulin Dosage Patent Publication

The European Patent Office published patent application EP3729459A1 for Glytec, LLC, covering insulin dosing and diabetes medication advising systems. The patent includes methods for computer-implemented insulin dosage recommendations and is classified under G16H (Health Informatics). The application names Robert Booth, Harry Hebblewhite, and Andrew Rhinehart as inventors.

Assay and Point of Care Device Utilizing Saliva for Neurological Diagnosis

The European Patent Office published patent application EP3721228A1 for Flotbi Inc., covering an assay and point-of-care device that uses saliva for diagnosis and treatment of neurological conditions affecting brain health. Inventors include Janigro, Dudas, and Rapp. The patent, originally filed November 11, 2021, covers IPC classifications related to immunological assays, medical diagnostics computing, and protein analysis.

Blood Treatment Apparatus with Control Unit Patent

The European Patent Office published patent application EP3618889A1 for Fresenius Medical Care Deutschland GmbH and Fresenius Medical Care Holdings, Inc., covering a blood treatment apparatus with a control unit configured for executing operating methods. The patent includes health informatics classifications (G16H 10/65, 20/17, 40/40, 40/63) and is designated across 31 European states.

Adhesive Preparation Management Method and Device

The European Patent Office published patent EP3437690A1 granting Nitto Denko Corporation rights to an adhesive preparation management method, module, and device. The patent, filed by inventors OKUMURA Keisuke and YOSHIOKA Ryoma, covers healthcare-related adhesive technologies classified under G16H 20/10 and various A61 medical device categories. The patent is validated in 41 designated contracting states across the European region.

Drug Dosing Recommendation Patent - Fresenius

European Patent Office published patent application EP3485405A1 for a drug dosing recommendation system filed by Fresenius Medical Care Deutschland GmbH. The patent application covers IPC classification G16H 20/10 and is designated for all EU member states including Germany, France, UK, Italy, Spain, and 25 additional extension states. Inventors are Carlo Barbieri and Flavio Mari.

CLOSED-LOOP BLOOD GLUCOSE CONTROL SYSTEMS AND METHODS

The European Patent Office published patent application EP3438858A1 for Diabeloop's closed-loop blood glucose control systems and methods. The patent covers automated insulin delivery technology combining continuous glucose monitoring with algorithmic processing to control blood glucose levels. Designated states include all EU member states plus other European countries.

Impedance Measurement System Patent

European Patent Office published patent EP3340874A1 for Impedimed Limited's impedance measurement system. The patent, filed by inventors Cosentino, Essex, and Miller, covers medical diagnostic devices using bioelectrical impedance analysis. The patent is designated for all European states including Germany, France, UK, Italy, and Spain.